Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Lakefront Biotherapeutics
Market Cap: €1.8b
A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
LKFT
€26.90
7D
4.7%
1Y
10.0%